CS259821B1 - Benzoic acid 2,6-dichloroanilide - Google Patents

Benzoic acid 2,6-dichloroanilide Download PDF

Info

Publication number
CS259821B1
CS259821B1 CS866329A CS632986A CS259821B1 CS 259821 B1 CS259821 B1 CS 259821B1 CS 866329 A CS866329 A CS 866329A CS 632986 A CS632986 A CS 632986A CS 259821 B1 CS259821 B1 CS 259821B1
Authority
CS
Czechoslovakia
Prior art keywords
dichloroanilide
benzoic acid
formula
water
preparation
Prior art date
Application number
CS866329A
Other languages
Czech (cs)
Other versions
CS632986A1 (en
Inventor
Jiri Strof
Rudolf Smrz
Lubos Dejmek
Vaclav Zoula
Original Assignee
Jiri Strof
Rudolf Smrz
Lubos Dejmek
Vaclav Zoula
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiri Strof, Rudolf Smrz, Lubos Dejmek, Vaclav Zoula filed Critical Jiri Strof
Priority to CS866329A priority Critical patent/CS259821B1/en
Publication of CS632986A1 publication Critical patent/CS632986A1/en
Publication of CS259821B1 publication Critical patent/CS259821B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Řešeni se týká 2,6-diChloranilldu kyseliny benzoové; tato nová látka slouží jako meziprodukt pro přípravu sodné soli diclofenacu, která je žádaným léčivem s protibolestlvým a protizánětlivým účinkem.The solution concerns 2,6-dichloroanilide of benzoic acid; this new substance serves as an intermediate for the preparation of diclofenac sodium, which is a desired drug with analgesic and anti-inflammatory effects.

Description

Vynález se týká 2,6-dichloranilidu kyseliny benzoové vzorce I

který je meziproduktem přípravy a-(2,6-di-chloranilino)-fenyloctové kyseliny, jejíž sodná sůl (diclofenac natrium] je rozšířeným léčivem s protibolestivým a protizánětlivým účinkem.

Nová sloučenina vzorce I se připravuje reakcí 2,6-dichloranilinu s benzoylchlori-dem za přítomnosti ekvivalentního množství pyridinu nebo terciárního aminu jako pro-tonakceptoru, v rozmezí teplot 20° až 110° Celsia; po zředění reakční směsi vodou se vyloučený surový 2,6-dichloranilid kyseliny benzoové t. t. 147 ° až 149 °C izoluje filtrací. Čistý 2,6-dichloranilid kyseliny benzoové jako bílá krystalická látka t. t. 149 0 až 150 0 Celsia, čistoty 99,93% (stanoveno plynovou chromatografií] se získá krystalizací z me-thanolu. Následující příklad přípravy sloučeniny podle vynálezu látku pouze dokládá, ale neomezuje. Příklad

Směs 16,2 g (0,10 molu) 2,6-dichlorahili-nu, 15,5 g (0,11 molu) benzoylchloridu a 50 ml pyridinu se za stálého míchání zahřívá 2 hod. na teplotu 100 °C; vzniklá hnědá reakční směs se ponechá zchladnout na 20 °C a za míchání se zředí 250 ml dest. vody. Vyloučená hnědá sraženina surového 2,6-dichloranilidu kyseliny benzoové se odsaje, promyje 150 ml dest. vody a usuší do konst. hmotnosti; získá se 22,3 g produktu tj. 82,1 % th. 98% čistoty (stanoveno plynovou chromatografií). Krystalizací surového produktu ze 150 ml methanolu se získá 17,0 g čistého (99,93%) 2,6-dichloranilidu kyseliny benzoové, bílé krystalické látky t. t. 149 c až 150 °C (Koffler).

The invention relates to benzoic acid 2,6-dichloroanilide of the formula I

which is an intermediate for the preparation of α- (2,6-di-chloroanilino) -phenylacetic acid, whose sodium salt (diclofenac sodium) is a widespread drug with an anti-inflammatory and anti-inflammatory effect.

The novel compound of formula I is prepared by reacting 2,6-dichloroaniline with benzoyl chloride in the presence of an equivalent amount of pyridine or a tertiary amine as a pro-tacceptor, at a temperature range of 20 ° to 110 ° Celsius; after diluting the reaction mixture with water, the crude benzoic acid 2,6-dichloroanilide precipitated is isolated by filtration at 147-149 ° C. Pure 2,6-dichloroanilide benzoic acid as a white crystalline solid m.p. 149-150 ° C, 99.93% purity (as determined by gas chromatography) is obtained by crystallization from methanol. Example

A mixture of 16.2 g (0.10 mol) of 2,6-dichloro-amine, 15.5 g (0.11 mol) of benzoyl chloride and 50 ml of pyridine was heated at 100 DEG C. for 2 hours with stirring; The resulting brown reaction mixture was allowed to cool to 20 ° C and diluted with 250 mL of dist. water. The precipitated brown precipitate of crude benzoic acid 2,6-dichloroanilide is filtered off with suction, washed with 150 ml of dist. water and dry to const. weight; 22.3 g of product is obtained, i.e. 82.1% th. 98% purity (as determined by gas chromatography). Crystallization of the crude product from 150 mL of methanol gave 17.0 g of pure (99.93%) benzoic acid 2,6-dichloroanilide, white crystalline solid, mp 149-150 ° C (Koffler).

Claims (1)

PREDMfiT vynalezu 2,6-dichloranilid kyseliny benzoové vzorce IBRIEF DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE INVENTION The present invention provides benzoic acid 2,6-dichloroanilide of formula I
CS866329A 1986-09-01 1986-09-01 Benzoic acid 2,6-dichloroanilide CS259821B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS866329A CS259821B1 (en) 1986-09-01 1986-09-01 Benzoic acid 2,6-dichloroanilide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS866329A CS259821B1 (en) 1986-09-01 1986-09-01 Benzoic acid 2,6-dichloroanilide

Publications (2)

Publication Number Publication Date
CS632986A1 CS632986A1 (en) 1988-03-15
CS259821B1 true CS259821B1 (en) 1988-11-15

Family

ID=5410078

Family Applications (1)

Application Number Title Priority Date Filing Date
CS866329A CS259821B1 (en) 1986-09-01 1986-09-01 Benzoic acid 2,6-dichloroanilide

Country Status (1)

Country Link
CS (1) CS259821B1 (en)

Also Published As

Publication number Publication date
CS632986A1 (en) 1988-03-15

Similar Documents

Publication Publication Date Title
DE69327890T2 (en) Process for the preparation of 2- (un) substituted 4-alkylimidazoles
SU575026A3 (en) Method of preparing 2,6-disubstituted 2-phenyliminoimidazolidines or salts thereof
JPS62238236A (en) Production of alkoxysalicylic acid derivative
JPS5916871A (en) Sulfonamide-based benzamides
US20080188667A1 (en) Azlactone compound and method for preparation thereof
SU639450A3 (en) Method of obtaining heterogeneous ring compounds or salts thereof
US4292431A (en) Process for the production of hydroxymethylimidazoles
KR20040039430A (en) Process for producing (2-nitrophenyl)acetonitrile derivative and intermediate therefor
US4107179A (en) Method for preparing ticrynafen
KR910004177B1 (en) Anilinopyrimidine derivatives
CN109553629A (en) A kind of preparation method of Cefuroxime Sodium intermediate E type impurity compound
SU1685935A1 (en) 2-[(benzo-2
CN1360569A (en) Method for preparation of Z-methoxy-4-(N-t-butylamino-carbonyl)benzenesulfonyl chloride
US4285878A (en) N-Phenyl-N'-cyano-O-phenylisoureas
KR100207247B1 (en) Process for the manufacture of anilinofumarate via chloromaleate or chlorofumarate or mixtures thereof
SU507235A3 (en) The method of obtaining 2n-3-isoquinolones
HU209543B (en) New method for production of alkanesulfonanilide-derivatives
SU882187A1 (en) 1,1-dioxo-3-hydroxythiolanyl-4-isothiouronic salts as initial substance for synthesis of 3,4-thriiranothiolan-1,1-dioxide
SU449053A1 (en) Method for producing 9-phenyl-11,14-dicyanoperhydroacridine derivatives
SU556726A3 (en) The method of obtaining sulfonylaminopyrimidine derivatives or their salts
KR810000198B1 (en) Method for preparing ticrynafen
KR820001277B1 (en) Process for preparation of 5-substituted picolinic acid derivatives
JPS59148770A (en) 2,4-dichloro-5-thiazole carboxaldehyde and manufacture
JP2000143618A (en) Synthetic method of asymmetric disulfide
SU639878A1 (en) Method of obtaining 6-amino-4-acylamido-2-mercaptopyrimidines